Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues

Cancer Chemotherapy and Pharmacology

Volumn 58, Issue 4, 2006, Pages 478-486

  Di Venosa, Gabriela ^a   Batlle, Alcira ^a   Fukuda, Haydée ^a   MacRobert, Alexander ^b   Casas, Adriana ^a,c  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NONE   (Argentina)

Author keywords

ALA derivatives; ALA esters; Aminolevulinic acid; In vivo distribution; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECEPTOR AFFINITY; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; TISSUE SPECIFICITY;

AMINOLEVULINIC ACID; ANIMALS; MALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; PORPHYRINS; TISSUE DISTRIBUTION;

EID: 33745726221     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-006-0186-9     Document Type: Article

References (23)

1. Dougherty T (1984) Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol 2:83-116
2. Baumgartner R, Huber R, Schulz H, Stepp H, Rick K, Gamarra F, Leberig A, Roth C (1996) Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J Photochem Photobiol B Biol 36:167-174
3. Kennedy J, Pottier R, Pross G (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol 6:143-148
4. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen H, Giercksky K, Nesland J (1995) ALA derivative-induced protoporphyrin IX build-up and distribution in human nodular basal cell carcinoma. Photochem Photobiol 61: Abstract 82S
5. Peng Q, Warloe K, Berg J, Moan M, Kongshaug K, Giercksky E, Nesland J (1997) 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 79:2282-2308
6. Casas A, Batlle A (2002) Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr Med Chem Anti-Cancer Agents 2:465-475
7. Casas A, Fukuda H, Di Venosa G, Batlle A (2001) Photosensitisation and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer 85:279-284
8. Perotti C, Casas A, Fukuda H, Sacca P, Batlle A (2002) ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice. Br J Cancer 87:790-795
9. Moan J, Ma L, Iani V (2001) On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer 92:139-143
10. Perotti C, Casas A, Fukuda H, Sacca P, Batlle A (2003) Topical application of ALA and ALA hexyl ester on a subcutaneous mammary adenocarcinoma: tissue distribution. Br J Cancer 88:432-437
11. Perotti C, Fukuda H, Di Venosa G, MacRobert A, Batlle A, Casas A (2004) Porphyrins synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Br J Cancer 90:1660-1665
12. Takeya H (1992) Preparation of 5-aminolevulinic acid alkyl esters as herbicides. Chem Abstr 116:189633m
13. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer 77:1-10
14. Batlle A (1997) (ed) Porfirias y Porfirinas. In: Aspectos Clinicos, Bioquímicos y Biología Molecular. Acta Bioquímica Clínica Latinoamericana. Buenos Aires, Argentina, pp 155-157
15. Mauzerall M, Granick S (1956) The occurrence and determination of 5-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 219:435-437
16. Di Venosa G, Fukuda H, Perotti C, Batlle A, Casas A (2004) A simple method for separating ALA from ALA derivatives using ionic exchange chromatography. J Photochem Photobiol B Biol 75:57-163
17. Van den Akker J, Iani V, Star W, Sterenborg H, Moan J (2000) Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72:681-689
18. Uehlinger P, Zellweger M, Wagnieres G, Juillerat-Jeanneret L, van den Bergh H, Lange N (2000) 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B Biol 54:72-80
19. Hansch C, Bjorkroth J, Leo A (1987) Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J Pharmacol Sci 76:663-687
20. Kloek J, Akkermans W, Beijersbergen van Henegouwen G (1998) Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 67:150-154
21. Roberts W, Hasan T (1992) Role of neovascular and vascular permeability on the tumor retention of photodynamic agents. Cancer Res 52:924-930
22. Moan J, Ma L, Juzeniene A, Iani V, Juzenas P, Apricena F, Peng Q (2003) Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int J Cancer 103:132-135
23. Casas A, Perotti C, Fukuda H, Rogers L, Butler A, Batlle A (2001) ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitisation. Br J Cancer 85:1740-1800